Long-Term Outcomes Similar for Cord Clamping, Umbilical Cord Milking
By Elana Gotkine HealthDay Reporter
TUESDAY, July 9, 2024 -- For nonvigorous term and near-term infants, long-term outcomes do not differ significantly with early cord clamping (ECC) and umbilical cord milking (UCM), according to a study published online July 1 in JAMA Network Open.
Anup C. Katheria, M.D., from the Sharp Mary Birch Hospital for Women & Newborns in San Diego, and colleagues examined the two-year outcomes of infants randomly assigned to receive UCM or ECC at birth in a secondary analysis of a trial that took place in 10 medical centers. A total of 1,730 near-term and full-term infants born at 35 to 42 weeks of gestation who were nonvigorous were included in the primary trial. Long-term outcomes were assessed in 971 children who had Ages and Stages Questionnaire, 3rd Edition (ASQ-3) scores available at age 2 years or died before age 2 years and for 927 children with Modified Checklist for Autism in Toddlers, Revised/Follow-Up (M-CHAT-R/F) questionnaire scores or who died before age 2 years.
The researchers found that maternal and neonatal characteristics were similar by treatment group. The median ASQ-3 scores were similar in the UCM and ECC groups (255 versus 255), with no significant differences in the subdomains of ASQ-3. Similar scores were also seen for medium- to high-risk M-CHAT-R/F scores (9 versus 8 percent for UCM and ECC).
"Considering the important previously reported short-term benefits of UCM to enhance placental transfusion, our study adds further support to this safe, facile, zero-cost intervention as a preferable practice compared with ECC," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
WEDNESDAY, May 21, 2025 -- Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do...
Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk
TUESDAY, May 20, 2025 -- Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published...
Buprenorphine for Opioid Use Disorder in Pregnancy Can Improve Outcomes
FRIDAY, May 2, 2025 -- For mothers with opioid use disorder (OUD), treatment with buprenorphine in pregnancy is associated with improved maternal and infant outcomes, according to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.